IP Library Granted Patent US 7,893,259
Granted Patent B2
US 7,893,259 · App. 12/415,256 · Granted Feb 22, 2011

Pyrido-pyrimidine derivatives, preparation thereof, and therapeutic use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,893,259
App. No.
12/415,256
Granted
Feb 22, 2011
Kind
B2
Abstract

The disclosure concerns pyrido[2,3-d]pyrimidine derivatives, their preparation and their therapeutic application, of general formula (I): and acid addition salts, hydrates and solvates thereof, as well as in the form of enantiomers, diastereoisomers and mixtures thereof. The disclosure also concerns methods for preparing said derivatives, pharmaceutical compositions containing a compound of general formula (I), and their therapeutic use.

Claims (15)

1. A compound of formula (II):

wherein:

R 1 is selected from the group consisting of (C 1 -C 6 )alkyl, (C 3 -C 7 )cycloalkyl, CH 2 COR 4 , phenyl and phenyl substituted with one or more substituents independently selected from hydroxy, halogen, or (C 1 -C 6 )alkyl; and

Ar 2 represents a phenyl group which is unsubstituted or substituted 1 to 5 times with substituents independently selected from a halogen atom or a (C 1 -C 4 )alkyl, trifluoromethyl or (C 1 -C 4 )alkoxy group.

2. The compound according to claim 1 wherein Ar 2 is selected from the group consisting of phenyl, 2-methoxyphenyl, 2,6-dichlorophenyl, 3,5-dimethoxyphenyl, 3,4-dimethoxyphenyl, 2,6-dibromophenyl, 2-bromo-6-chlorophenyl, 2,4-dichlorophenyl and 3,5-dichlorophenyl.

3. The compound according to claim 1 wherein R 1 is selected from ethyl, tert-butyl and phenyl.

4. A compound of the formula:

wherein:

R 1 is selected from the group consisting of (C 1 -C 6 )alkyl, (C 3 -C 7 )cycloalkyl, CH 2 COR 4 , phenyl and phenyl substituted with one or more substituents independently selected from hydroxy, halogen, or (C 1 -C 6 )alkyl; and

Ar 2 represents a phenyl group which is unsubstituted or substituted 1 to 5 times with substituents independently selected from a halogen atom or a (C 1 -C 4 )alkyl, trifluoromethyl or (C 1 -C 4 )alkoxy group.

5. The compound according to claim 4 wherein R 1 is selected from ethyl, tertiobutyl and phenyl.

6. The compound according to claim 4 wherein Ar 2 is selected from the group consisting of phenyl, 2-methoxyphenyl, 2,6-dichlorophenyl, 3,5-dimethoxyphenyl, 3,4-dimethoxyphenyl, 2,6-dibromophenyl, 2-bromo-6-chlorophenyl, 2,4-dichlorophenyl and 3,5-dichlorophenyl.

7. A compound of the formula:

wherein Ar 2 represents a phenyl group which is unsubstituted or substituted 1 to 5 times with substituents independently selected from a halogen atom or a (C 1 -C 4 )alkyl, trifluoromethyl or (C 1 -C 4 )alkoxy group.

8. The compound according to claim 7 wherein Ar 2 is selected from the group consisting of phenyl, 2-methoxyphenyl, 2,6-dichlorophenyl, 3,5-dimethoxyphenyl, 3,4-dimethoxyphenyl, 2,6-dibromophenyl, 2-bromo-6-chlorophenyl, 2,4-dichlorophenyl and 3,5-dichlorophenyl.

Assignments (1)
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →